Utilizing Genmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Utilizing genmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Utilizing Genmark Today - Breaking & Trending Today

Roche purchases shares in tender offer for GenMark Diagnostics, Inc.


Share:
Basel, 22 April 2021 - Roche ((SIX: RO, ROG, OTCQX:RHHBY) and GenMark Diagnostics, Inc. today announced that Roche s wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) at a price of USD 24.05 per share in cash. The tender offer expired at 12:00 midnight, Eastern Time, at the end of the day on 21 April 2021 and was not extended.
Roche has been advised by Citibank, N.A., the depositary for the tender offer, that a total of approximately 61,201,761 shares of GenMark s common stock were validly tendered and not validly withdrawn in the tender offer (excluding shares tendered by notice of guaranteed delivery for which certificates have not yet been received ), which represent approximately 82.89% of the total number of shares of GenMark s common stock outstanding. ....

United States , Nathalie Meetz , Daniel Grotzky , Thomas Schinecker , Patrick Barth , Karsten Kleine , Geronimo Acquisition Corp , Genmark Diagnostics Inc , Exchange Commission , Securities Exchange , Roche Group , Pharmaceuticals Industry , Roche Group Media Relations , Genmark Diagnostics , Geronimo Acquisition , Eastern Time , Genmark Diagnostic , Mark Diagnostics , Utilizing Genmark , True Sample To Answer Solution , World Health Organization Model Lists , Essential Medicines , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Securities Act , Securities Exchange Act ,

Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample

F. Hoffmann-La Roche Ltd: Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample

F. Hoffmann-La Roche Ltd: Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Nathalie Meetz , Daniel Grotzky , Jon Kaspar Bayard , Karl Mahler , Scott Mendel , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Lisa Tuomi , Thomas Schinecker , Loren Kalm , Patrick Barth , Karsten Kleine , Sidley Austin , Roche Group , Pharmaceuticals Industry , Jp Morgan Securities , Roche Group Media Relations , Genmark Diagnostics , Respiratory Pathogen Panels , Hart Scott Rodino Antitrust Improvements Act , Mark Diagnostics , Utilizing Genmark , True Sample To Answer Solution ,

Investegate |GenMark Diagnostics, Inc. Announcements | GenMark Diagnostics, Inc.: Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels


Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the publication of a manuscript in
Frontiers in Cellular and Infection Microbiology that highlights strong performance and the potential clinical impact of the ePlex Blood Culture Identification (BCID) Panels. The study, “Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex
® Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia,” looked prospectively at the identification of pathogens and antimicrobial resistance genes, as well as retrospectively analyzing clinical outcomes, based on eP ....

Yvan Caspar , Lauren Martin , Grenoble Alpes University Hospital , Exchange Commission , University Practitioner , Bacteriology Laboratory , National Reference Center , Genmark Diagnostics Inc , Study Highlights Potential Clinical Value , Blood Culture , Mark Diagnostics , Infection Microbiology , Plex Blood Culture Identification , Microbiological Performance , Potential Clinical Impact , Blood Culture Identification Panels , Rapid Diagnosis , Plex Blood Culture Identification Panels , Hospital University Practitioner , Grenoble Alpes University , Fungal Pathogen , Utilizing Genmark , True Sample To Answer Solution , Investegate Announcements , Investegate Company Announcements , Genmark Diagnostics ,